Abnormal development of hypoxanthine-guanine phosphoribosyltransferase-deficient CNS neuroblastoma

Brain Res. 2001 Nov 9;918(1-2):20-7. doi: 10.1016/s0006-8993(01)02909-2.

Abstract

Lesch-Nyhan syndrome encompasses a host of neurological symptoms, caused by a deficiency of the purine salvage enzyme, hypoxanthine-guanine phosphoribosyltransferase (HGPRT). How the absence of this enzymes activity affects development of the nervous system is unknown. In this study, we examined the ability of N2aTG, a HGPRT-deficient neuroblastoma and its HGPRT-positive counterpart to proliferate and differentiate at various densities. In summary, N2aTG cells proliferated less and differentiated more than N2a cells, with the former cells exhibiting enhanced sensitivity to the effects of low-density culture. Given the homogeneity of this neuroblastoma cell line and its use in studies of neuronal development, the present study indicates that N2aTG cells may prove a suitable in vitro model for the study of non-dopaminergic neuronal development in Lesch-Nyhan syndrome.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Count
  • Cell Differentiation / physiology*
  • Cell Division / physiology*
  • Cell Size / physiology
  • Central Nervous System / abnormalities
  • Central Nervous System / enzymology*
  • Central Nervous System / physiopathology
  • Humans
  • Hypoxanthine Phosphoribosyltransferase / deficiency*
  • Hypoxanthine Phosphoribosyltransferase / genetics
  • Lesch-Nyhan Syndrome / enzymology*
  • Lesch-Nyhan Syndrome / physiopathology
  • Neurites / enzymology
  • Neurites / ultrastructure
  • Neuroblastoma
  • Neurons / cytology
  • Neurons / enzymology*
  • Tetrazolium Salts
  • Thiazoles
  • Tumor Cells, Cultured

Substances

  • Tetrazolium Salts
  • Thiazoles
  • Hypoxanthine Phosphoribosyltransferase
  • thiazolyl blue